The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The findings align with recent recommendations from the American Dental Association to avoid opioids as first-line pain treatment. Feldman said she hopes they will change prescribing practices.

Learn about pain management options during root canal therapy, including anesthesia, sedation, and post-treatment care, for a comfortable dental experience.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

However, many individuals in dental pain accidentally overdose on these drugs, which may lead to more serious health problems. To investigate the extent of analgesic overdosing in patients with dental ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Dr. Kalasho also recommends trying over-the-counter anti-inflammatory medication, such as ibuprofen, for tooth pain relief.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Virtual reality has been a standout technology in the medical industry since the turn of the decade. From its use as a ...